Zepzelca (Lurbinectedin)

Zepzelca is an alkylating medication used for the treatment of adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy.

Recommended Dosage: The recommended dosage of Zepzelca (Lurbinectedin for Injection) is 3.2 mg/m2 by intravenous infusion over 60 minutes every 21 days until the disease is progressive or unacceptable toxicity occurs. 

• Start therapy with Lurbinectedin only in case the absolute neutrophil count (ANC) is minimum 1,500 cells/mm3 and platelet count is minimum 100,000/mm3.
• Lurbinectedin can be responsible for causing myelosuppression. Blood counts need to be assessed including neutrophil count and platelet count before every single administration.
• The zepzelca 4 mg injection can be responsible for causing hepatotoxicity. Monitor liver function tests, prior to initiating therapy, periodically while on therapy, and as clinically indicated. 
• Women should not conceive pregnancy and should not breastfeed during treatment with injection Zepzelca and for at least 14 days after the last dose. 
• Patients should inform their health specialists of all concomitant medicines, herbal and dietary supplements. Patients should avoid grapefruit products while on treatment with Lurbinectedin. 

What is the Generic Name for the trade name drug ZEPZELCA®?

Lurbinectedin is the Generic Name for the trade name drug ZEPZELCA®.

What is the Manufacturer Name of ZEPZELCA®?

ZEPZELCA® is manufactured by PharmaMar.

Is ZEPZELCA® approved by the FDA?

Yes, ZEPZELCA® is approved by the FDA. Date of approval: June 15, 2020.

What is ZEPZELCA®?

ZEPZELCA® (Lurbinectedin) is an FDA-approved medicine used to treat adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy.

What is the dosage and form of ZEPZELCA® supplied?

ZEPZELCA® is supplied as Injection: 4 mg lyophilized powder in a single-dose vial for reconstitution and intravenous administration.

What are the most common side effects due to ZEPZELCA®?

The most common side effects due to ZEPZELCA® include: fatigue, nausea, decreased appetite, vomiting, constipation, diarrhea, and musculoskeletal pain.

How much does Lurbinectedin cost in India?

The cost of lurbinectedin in India is reasonable. In order to procure this metastatic small cell lung cancer (SCLC) medicine authentically, you can call or WhatsApp +1-647-818-4196 or send mail to info@urgentmeds.in.

What are the storage conditions of ZEPZELCA®?

Store vials of ZEPZELCA at 20°C to 25°C (68°F to 77°F); excursions are permitted between 15°C and 30°C (59°F and 86°F). Protect from light.

Is it safe to buy ZEPZELCA® online?

Yes, it is safe to buy ZEPZELCA® online. Always look for a legitimate, WHO-GDP and ISO-certified pharmaceutical wholesaler/distributor/supplier.

Urgent Meds can facilitate the supply of ZEPZELCA (prescription medicine) to locations worldwide while adhering to legal requirements.

Urgent Meds is able to source ZEPZELCA (Cancer Treatment Medicines) from across the globe and has the ability to supply. Urgent Meds offers its customers worldwide access to the best available treatment.

Urgent Meds is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the patient’s address only from New Delhi, India.